透析患者における脂質を使用した栄養管理

DOI Web Site Web Site

書誌事項

タイトル別名
  • Lipid management for hemodialysis patients
  • トウセキ カンジャ ニ オケル シシツ オ シヨウ シタ エイヨウ カンリ

この論文をさがす

抄録

Chronic kidney disease develops due to lifestyle-related diseases such as diabetes and hypertension, increases the risk of end stage renal failure and cardiovascular disease. Patients with end stage renal failure needs renal replacement therapy such as hemodialysis （HD）. Each serum lipid level of HD patients is different from that in healthy people. In particular, they are characterized by high levels of triglyceride and low levels of high-density lipoprotein cholesterol. The target lipid management for HD patients should be LDL-Cho levels of less than 120 mg/dL. Whereas, non-HDL-Cho levels of less than 150 mg/dL may also be used as the management standard. In 2004, the Statistical Survey Committee of the Japanese Society for Dialysis Therapy conducted a survey on relationship with lipid-related markers and each factor （all-cause mortality, heart failure death, myocardial infarction, cerebral infarction and cerebral hemorrhage） in HD patients. As a result, it was reported that each lipid level was associated with the development of these factors. According to dietary reference standards for CKD, it suggests that the target amount of lipid for HD patients can be adapted to the target amount of healthy people. In total energy, total lipid is 20%〜30% and saturated fatty acids is less of 7% . Because dialysis patients are prone to undernutrition, adequate energy intake is essential in their nutritional management. It is necessary for HD patients to understand lipid metabolism and incorporate lipids into their daily diet for maintaining their energy intake.

収録刊行物

  • 脂質栄養学

    脂質栄養学 30 (1), 33-42, 2021

    日本脂質栄養学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ